How many patents does
Ucb Biopharma have?
patents
2,967
families
287
granted
514
applications
2,453
US
421
EP
303
WO
260
CN
204
GB
179
JP
171
KR
89
RoW
1,340
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Ucb Biopharma
Top ten assignees appearing on patents
2009 - 2018
| ucb biopharma | 1367 |
| ucb pharma | 999 |
| lts lohmann therapie-systeme | 48 |
| sanofi | 36 |
| biogen idec ma | 29 |
| neuropore therapies | 23 |
| bespak europe | 14 |
| ucb | 13 |
| biogen ma | 10 |
| ucb farchim | 7 |
Ucb Biopharma
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate | 57 | 2008 |
| auto-injector | 53 | 2011 |
| antibody molecules which bind il-17a and il-17f | 49 | 2011 |
| systems for administering medication for rheumatoid arthritis patients | 49 | 2008 |
| novel tnfa structure for use in therapy | 45 | 2015 |
| 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses | 45 | 2000 |
| binding proteins, including antibodies, antibody derivatives and antibody fragments, tha… 🛈 | 43 | 2007 |
| antibodies specific for human cd22 and their therapeutic and diagnostic uses | 42 | 2002 |
| antibody molecules which bind il-17a and il-17f | 41 | 2006 |
| antibody molecules having binding specificity for human il-13 | 41 | 2009 |